Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yongseon Cho is active.

Publication


Featured researches published by Yongseon Cho.


Respirology | 2009

Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells

Yongseon Cho; Mee-Ja Park; Mira Park; Sun Seek Min; Jaeyong Yee; Chan Kim; Minsoo Han; Seung-Ho Han

Background and objective:  Lung cancer is the most common cause of cancer death in men and women worldwide. The mechanism of cell death induced by CAY10404, a highly selective cyclooxygenase‐2 inhibitor, was evaluated in three non‐small cell lung cancer (NSCLC) cell lines (H460, H358, H1703).


Tuberculosis and Respiratory Diseases | 2016

Risk Factors for Mechanical Ventilation in Patients with Scrub Typhus Admitted to Intensive Care Unit at a University Hospital

Kyoung Min Moon; Min Soo Han; Ch'ang Bum Rim; Jun Ho Lee; Min Seok Kang; Ji Hye Kim; Sang Il Kim; Sun Young Jung; Yongseon Cho

Background The purpose of this study was to evaluate the risk factors for mechanical ventilation in the patients with scrub typhus admitted to intensive care unit (ICU) at a university hospital. Methods We retrospectively selected and analyzed clinical data from the medical records of 70 patients (32 men, 38 women) admitted to the ICU with scrub typhus between 2004 and 2014. The patients had a mean±standard deviation age of 71.2±11.1 years and were evaluated in two groups: those who had been treated with mechanical ventilation (the MV group, n=19) and those who had not (the non-MV group, n=51). Mean ages of the MV group and the non-MV group were 71.2±8.3 years and 71.2±11.1 years, respectively. Results Significant differences between the two groups were observed with respect to acute respiratory failure (p=0.008), Acute Physiology and Chronic Health Evaluation (APACHE) II score (p=0.015), Sequential Organ Failure Assessment (SOFA) score (p=0.013), death (p=0.014), and ICU duration (p<0.01). Multivariate analysis indicated that the following factors were significantly associated with mechanical ventilation: acute respiratory failure (p=0.011), SOFA score (p=0.005), APACHE II score (p=0.011), platelet count (p=0.009), and lactate dehydrogenase (LDH) (p=0.011). Conclusion Thus, five factors-acute respiratory failure, SOFA score, APACHE II score, platelet count, and LDH-can be the meaningful indicators for mechanical ventilation for the patients with scrub typhus admitted to ICU.


Tuberculosis and Respiratory Diseases | 2016

IgG4-Related Lung Disease without Elevation of Serum IgG4 Level: A Case Report

Min Kyu Kang; Yongseon Cho; Minsoo Han; Sun Young Jung; Kyoung Min Moon; Jinyoung Kim; Ju Ri Kim; Dong Kyu Lee; Jun Hyung Park; So Hee Chung

Since IgG4-related pancreatitis was first reported in 2001, IgG4-related disease has been identified in other organs such as salivary gland, gallbladder, thyroid, retroperitoneum and kidney; but lung invasion is rare. A 63-year-old man presented with hemoptysis at the pulmonary clinic and chest computed tomography revealed about 4.1 cm irregular shaped mass with spiculated margin at the left upper lobe. Despite no elevation of serum IgG4 level, he was finally diagnosed as IgG4-related lung disease by transthoracic needle biopsy. After treatment with oral glucocorticoids, hemoptysis disappeared and the size of lung mass was decreased.


Tuberculosis and Respiratory Diseases | 2015

Agranulocytosis Induced by Ethambutol in a Patient with Pulmonary Tuberculosis

Kyoung Min Moon; Min Soo Han; So Hee Chung; Ju Ri Kim; Jinyoung Kim; Sun Young Jung; Yongseon Cho

We report a case of agranulocytosis caused by ethambutol in a 79-year-old man with pulmonary tuberculosis. He was referred for fever and skin rash developed on 21th day after antituberculosis drugs (isoniazid, rifampicin, ethambutol, and pyrazinamide) intake. Complete blood count at the time of diagnosis of pulmonary tuberculosis was normal. On the seventh admission day, agranulocytosis was developed with absolute neutrophil count of 70/µL. We discontinued all antituberculosis drugs, and then treated with granulocyte colony-stimulating factor. Three days later, the number of white blood cell returned to normal. We administered isoniazid, pyrazinamide, and ethambutol in order with an interval. However, fever and skin rash developed again when adding ethambutol, so we discontinued ethambutol. After these symptoms disappeared, we added rifampicin and ethambutol in order with an interval. However after administering ethambutol, neutropenia developed, so we discontinued ethambutol again. He was cured with isoniazid, rifampicin, and pyrazinamide for 9 months.


Tuberculosis and Respiratory Diseases | 2004

A Case of Pellagra Induced by Isoniazid during Treatment of Pulmonary Tuberculosis

Ho Seok Jeon; Min Soo Han; Ju Eui Ahn; Yang Deok Lee; Yongseon Cho


Tuberculosis and Respiratory Diseases | 2003

A Case of Primary Malignant Fibrous Histiocytoma of the Diaphragm

Jaejun Shim; Yongseon Cho; Hyun Sook Kim; Hye Sook Choi; Cheon Woong Choi; Jee Hong Yoo; Hong Mo Kang; Moon Ho Yang


Chest | 2016

Factors Associated With TB Mortality

Yongseon Cho


The Korean Journal of Critical Care Medicine | 2015

Diffuse Alveolar Hemorrhage Confirmed by Bronchoalveolar Lavage in a Patient with Hemoptysis after Sildenafil Use for Erectile Dysfunction

Kyoung Min Moon; Sun Young Jung; Min Soo Han; Yongseon Cho; Young Min Rah; Jong Woo Kim


american thoracic society international conference | 2011

The Role Of VEGF, Angiopoietin-1 And Angiopoietin-2 In Scrub Typhus Complicated With Interstitial Pneumonia

Yang Deok Lee; Yongseon Cho; Dong Jib Na; Min Soo Han; Sung Kyu Lee; Haing Woon Baik; Jung Joo Hwang


Tuberculosis and Respiratory Diseases | 2011

Issues on Safety of Long-Acting Muscarinic Antagonist

Yang Deok Lee; Yongseon Cho; Min Soo Han

Collaboration


Dive into the Yongseon Cho's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge